BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 2584933)

  • 1. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
    Mourad W; Scholl P; Diaz A; Geha R; Chatila T
    J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
    Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells.
    Fuleihan R; Mourad W; Geha RS; Chatila T
    J Immunol; 1991 Mar; 146(5):1661-6. PubMed ID: 1847171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
    Wood SC; Holsapple MP
    Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway.
    Haregewoin A; Edwin C; Hom RC; Finberg R
    Immunol Invest; 1994 Nov; 23(6-7):413-20. PubMed ID: 7851959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
    Spertini F; Spits H; Geha RS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
    Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
    Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
    Hofer MF; Lester MR; Schlievert PM; Leung DY
    Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1.
    Shimonkevitz R; Boen E; Malmstrom S; Brown E; Hurley JM; Kotzin BL; Matsumura M
    Infect Immun; 1996 Apr; 64(4):1133-9. PubMed ID: 8606069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
    Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
    Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
    Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
    J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
    Pontzer CH; Russell JK; Johnson HM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
    Scholl PR; Diez A; Geha RS
    J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
    Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.